<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00520715</url>
  </required_header>
  <id_info>
    <org_study_id>FQ/EPI</org_study_id>
    <nct_id>NCT00520715</nct_id>
  </id_info>
  <brief_title>Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards</brief_title>
  <official_title>Epidemiology and Risk Factors Study of the Carriage of Fluoroquinolone Resistant Bacteria in the Commensal Flora of Patients Hospitalised in Medical Wards</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Pour le Recherche en Infectiologie et en Médecine Interne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pr Bruno Fantin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Association Pour le Recherche en Infectiologie et en Médecine Interne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emergence of bacterial resistance to antibiotics, which is a major public health issue,
      appears to involve predominantly commensal flora. No data exists concerning risk factors for
      the carriage of fluoroquinolone resistant bacteria in the flora of hospitalised patients. We
      will conduct a prospective open study including all unselected patients hospitalised in
      medical wards of one hospital. Nasal, pharyngeal and rectal swabs will be performed upon
      admission as well as a review of potential risk factors, after patient's information and
      acceptance. Resistance testing aiming 3 pathogens (Staphylococcus, Streptococcus and E. coli)
      will be performed on all specimens, and a case control study will compare risk factors from
      the resistant and non-resistant groups, for each pathogen. A thousand patients should be
      included in a year's time. This work could help understand risk factors involved in the
      carriage of fluoroquinolone resistant pathogens, potentially responsible for invasive
      infections and inter-patient transmission of resistance. Limiting bacterial resistance and
      transmission is a goal that can be successfully undertaken only if resistance mechanisms, but
      also risk factors of acquiring resistant bacteria are better understood.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">640</enrollment>
  <condition>Colonization</condition>
  <condition>Multi Drug Resistant Bacteria</condition>
  <condition>Hospitalized Patients</condition>
  <arm_group>
    <arm_group_label>Patients at hospital admission</arm_group_label>
    <description>Patients at hospital admission in medical wards on our tertiray care hospital (Hôpital Beaujon, Clichy, France).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        adults patients at hospital admission hospital stay &gt;24 hours informed consent required
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all adult patients admitted to the internal medicine, oncology, cardiology and
             geriatric unit of Beaujon Hospital, Clichy, France.

          -  patient agreement

        Exclusion Criteria:

          -  Age &lt; 18

          -  patient refusal or incapable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victoire de Lastours, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Beaujon</name>
      <address>
        <city>Clichy</city>
        <state>Ile de France</state>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2007</study_first_submitted>
  <study_first_submitted_qc>August 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2007</study_first_posted>
  <last_update_submitted>June 22, 2015</last_update_submitted>
  <last_update_submitted_qc>June 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Association Pour le Recherche en Infectiologie et en Médecine Interne</investigator_affiliation>
    <investigator_full_name>Dr Victoire de Lastours</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>fluoroquinolone resistance</keyword>
  <keyword>commensal flora</keyword>
  <keyword>carriage</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluoroquinolones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

